MoneyWorks4Me

Shree Ganesh Biotech (India) informs about disclosure

27 Apr 2022 Evaluate

Shree Ganesh Biotech (India) has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shah Enterprise.

The above information is a part of company’s filings submitted to BSE.

Peers